20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
High-Stability Daptomycin Composition For Injection, And Preparation Method Therefor And Use Thereof
#302LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND METHOD FOR PREPARATION THEREOF
#303PROBIOTIC SKIN FORMULATIONS
#304CONJUGATE PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF
#305LONG LASTING EFFECT OF NEW BOTULINUM TOXIN FORMULATIONS
#306PAIRING PROBIOTICS AND PREBIOTICS, METHODS FOR GROWTH AND USE, SEPARATELY AND IN COMBINATION
#307REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES
#308LYOPHILIZATION SYSTEMS AND METHODS
#309METHOD FOR PRODUCING A LYOPHILIZED COMPOSITION COMPRISING POLYCLONAL IGM AND COMPOSITION OBTAINED
#310C1-ESTERASE INHIBITOR PREPARATION
#311TRADITIONAL CHINESE MEDICINE FERMENTED PREPARATION FOR PREVENTING AND TREATING GOUT, ITS PREPARATION METHOD AND APPLICATION
#3125-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulations
#313GUAIANOLIDE OLIGOMERS, PREPARATION METHOD AND APPLICATION
#314ORAL DELIVERY OF THERAPEUTIC AGENTS
#315Methods using freeze-dried platelet derivative compositions for restoring hemostasis in a subject
#316ENCAPSULATED MICROPARTICLES AND NANOPARTICLES OF DIMETHYLTRIPTAMINES
#317DIHYDROMYRICETIN SPRAY-DRIED DISPERSION FORMULATIONS AND METHODS FOR FORMING THEM
#318SOLID DELTA9-TETRAHYDROCANNABINOL (DELTA9-THC) COMPOSITIONS
#319Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle
#320METHODS FOR FREEZING AND FREEZE-DRYING LIPID NANOPARTICLES (LNPs) AND LNPs OBTAINED WITH THE SAME
#321AN INJECTABLE POLYHYDROXYALKANOATE MICROSPHERE AND A PREPARATION METHOD THEREOF
#322USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
#323PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF
#324FECAL MICROBIOTA TRANSPLANT COMPOSITIONS AND METHODS OF MANUFACTURE
#325BLADDER PERFUSION PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#326PACKAGE AND METHOD FOR PRODUCING THE SAME
#327TARGET RESIDUAL MOISTURE CONTENT FOR LYOPHILIZED DRUG PRODUCT
#328Albumin-Free Botulinum Toxin Formulations
#329TETRAZOLE DERIVATIVES
#330RESINIFERATOXIN COMPOSITIONS
#331THROMBIN SOLUTION AND METHODS OF USE THEREOF
#332Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
#333Formulation for Co-Administration of Q-GRFT and Tenofovir
#334Extracts for the Regeneration of Ligaments
#335ACCELERATED METHOD OF MAKING LYOPHILIZED PROTEIN FORMUALTIONS
#336Composition containing a somatostatin analogue for radiopharmaceutical use
#337Long-Acting Growth Hormone Treatment
#338METHOD FOR TREATING CELLS
#339LYOPHILIZED FORMULATION SOLUTION AND LYOPHILIZED FORMULATION, AND METHOD AND USE THEREOF
#340AMORPHOUS (A-POLYMORPHIC) PSILOCYBIN
#341PHARMACEUTICAL SALTS OF A CHK-1 INHIBITOR
#342LYOPHILIZED PREPARATION OF CYTOTOXIC DIPEPTIDES
#343FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF
#344Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same
#345METHODS OF TREATING OR PREVENTING STENT THROMBOSIS
#346[6R]-MTHF IN B6 ENHANCED 5-FU BASED CHEMOTHERAPY OF PANCREATIC CANCER
#347LYOPHILISED FORMULATIONS OF mRNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES
#348FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF
#349PHARMACEUTICAL COMPOSITION OF ANTI-IL4R ANTIBODY AND USE THEREOF
#350METHOD FOR PRODUCING HUMAN PLASMA-DERIVED FACTOR VIII / VON WILLEBRAND FACTOR AND COMPOSITION OBTAINED
#351FIBRINOGEN COMPOSITIONS AND METHODS OF PREPARATION
#352ANTI-FATIGUE LACTOBACILLUS COMPOSITION AND METHOD OF PROMOTING ANTI-FATIGUE PERFORMANCE AFTER AEROBIC EXERCISE OF SUBJECT IN NEED THEREOF BY USING THE SAME
#353NON-STEROID ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION
#354BACTERIAL TREATMENT FOR ATOPIC DERMATITIS
#355Lyophilized Vortioxetine Pamoate Powder for Injection and Preparation Method Therefor
#356COMPOSITIONS COMPRISING EXON SKIPPING OLIGONUCLEOTIDE CONJUGATES FOR TREATING MUSCULAR DYSTROPHY
#357PEPTIDES AND ANTIGEN BINDING PROTEINS FOR USE IN IMMUNOTHERAPY AGAINST FIBROLAMELLAR HEPATOCELLULAR CARCINOMA (FL-HCC) AND OTHER CANCERS
#358MINERAL-COATED SUBSTRATES FOR STABILIZATION OF RNA-BASED THERAPEUTIC COMPOSITIONS
#359PHARMACEUTICAL COMPOSITION CONTAINING ANTI-TROP2 ANTIBODY DRUG CONJUGATE AND ITS APPLICATION
#360USE OF A PHOSPHOLIPID AS A CRYSTALLIZATION INHIBITOR
#361PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORESHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME
#362Bactericidal and virucidal pharmaceutical composition
#363COCHLEATES MADE WITH SOY PHOSPHATIDYLSERINE
#364METHOD OF RECONSTITUTING LYOPHILIZED FORMULATION
#365EXOSOMES COMPRISING CORONAVIRUS-DERIVED ANTIGEN PROTEIN OR GENE ENCODING SAME PROTEIN, AND USE OF SAME
#366PHARMACEUTICAL COMPOSITION OF PCSK9 INHIBITOR AND GLP-1 RECEPTOR AGONIST
#367COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS
#368STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION
#369METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF
#370LYOPHILIZED POWDER CONTAINING BORON COMPLEX AND METHOD OF FORMING THE SAME
#371FORMULATION OF FURIN INHIBITOR FOR INHALATION
#372ANTIMICROBIAL COMPOSITIONS
#373NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#374COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#375PHARMACEUTICAL COMPOSITION
#376PRODUCTION OF A PROBIOTIC COMPOSITION
#377METHODS FOR TREATING SYSTEMIC SCLEROSIS
#378Liquid Protein Formulations Containing Ionic Liquids
#379LOW-SORBING GLYBURIDE FORMULATION AND METHODS
#380DRIED COSMETIC PREPARATION FOR REHYDRATION AND USE
#381MALLEABLE CONTROLLED RELEASE LOCAL ANESTHETIC WITH HEMOSTATIC COMPOSITION
#382FORMULATIONS OF TEGAVIVINT
#383NUCLEIC ACID SENSOR AGONIST COMPOSITIONS AND USES THEREOF
#384USE OF AMINO ACIDS AS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS
#385Pharmaceutical Composition for Treatment of Mucopolysaccharidosis Type 1
#386NOVEL LIPOPEPTIDE FORMULATION
#387COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH FUNGI AND OTHER PATHOGENIC MICROBES
#388SOLUTION FOR PRESERVING EXTRACELLULAR VESICLES/EXOSOMES, METHOD FOR PRESERVING THE SAME, AND MIXED SOLUTION THEREOF
#389High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
#390SARS-CoV-2 RNA vaccine compositions and methods of use
#391Pharmaceutical Complex for Radioprotection, Preparation Method, and Applications thereof
#392CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD
#393CD40 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF
#394VEDOLIZUMAB FORMULATION
#395IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#396NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#397A WATER SOLUBLE OR WATER DISPERSIBLE BOLUS ARTICLE
#398DILTIAZEM HYDROCHLORIDE AND PREGABALIN COMPOSITION, METHOD FOR PREPARING THE SAME, AND USAGE THEREOF
#399PHARMACEUTICAL FORMULATIONS
#400FREEZE-DRIED COMPOSITION CONTAINING ANTI-HER2 DRUG CONJUGATE, FREEZE-DRIED PREPARATION AND PREPARATION METHOD THEREFOR AND USE THEREOF
#401PYRROLO[2,3-D]PYRIMIDIN-2-ONE ANTIMICROBIAL COMPOUNDS
#402SOLID COMPOSITION, FREEZE-DRYING METHOD AND GLASS VIAL
#403USES OF IL-13 ANTAGONISTS FOR TREATING ATOPIC DERMATITIS
#404Compositions and Methods for Delivering a Bacterial Metabolite to a Subject
#405TETRODOTOXIN LIQUID FORMULATIONS
#406LYOPHILIZATION METHODS FOR PREPARING LIPID FORMULATED THERAPEUTICS
#407COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE MULTI-TARGETED ANTIGENS
#408LARGE-SCALE FLAVIVIRAL VACCINE PRODUCTION AND MANUFACTURE
#409COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE
#410PHARMACEUTICAL COMPOSITION COMPRISING A DIPHENYLPYRAZINE DERIVATIVE
#411MANUFACTURING METHOD OF MEDICATION
#412Dried nanoparticle compositions
#413BIVALENT LIGANDS TO UNDERSTAND DIMERIZATION OF THE MU OPIOID RECEPTOR AND THE CHEMOKINE RECEPTOR CCR5 IN NEUROLOGICAL DISORDERS
#414Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#415COMPOSITION COMPRISING EGG YOLK AND BURNT CERAL POWDER FOR WOUND HEALING
#416USE OF MALTODEXTRIN AS AN EXCIPIENT
#417SUSTAINED-RELEASE INJECTABLE COMPOSITION CONTAINING NALTREXONE AND METHOD FOR PREPARING SAME
#418Polymer particles for neutrophil injury
#419TREATMENT OF GLAUCOMA USING ENDOTHELIN RECEPTOR ANTAGONISTS
#420FRUIT AND/OR VEGETABLE BASED COMPOSITIONS AND METHODS OF PREPARING THE SAME
#421METHODS AND FORMULATIONS FOR TREATING VASCULAR DISEASE
#422Liquid Protein Formulations Containing Viscosity-Lowering Agents
#423LYOPHILIZED FORMULATIONS OF CD73 COMPOUNDS
#424DEVELOPMENT OF COVID-19 VACCINE USING A DUAL TLR LIGAND LIPOSOME ADJUVANT
#425CARTILAGE EXTRACT WITH EFFECT OF IMPROVING IMMUNE RESPONSE, PREPARATION METHOD THEREFOR, AND USE THEREOF
#426PHARMACEUTICAL COMPOSITION OF (S)-KETOROLAC AND PREPARATION METHOD THEREFOR
#427Stable Aqueous Pharmaceutical Composition or Freeze-Dried Pharmaceutical Composition
#428ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS
#429VACCINE COMPOSITION FOR PREVENTING SARS-COV-2
#430INSULIN FORMULATIONS AND METHODS OF USING SAME IN PRETERM INFANTS
#431Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
#432STABLE DOCETAXEL ALBUMIN NANOPARTICLE COMPOSITION
#433CONTINUOUS THROUGHPUT LYOPHILIZER-POWDER FILLER WITHIN A STERILE BOUNDARY
#434COMPOSITIONS AND METHODS FOR TREATING CANCER WITH SUBCUTANEOUS ADMINISTRATION OF ANTI-PD1 ANTIBODIES
#435IMMUNOTOXINS, FORMULATIONS THEREOF AND THEIR USE IN MEDICINE
#436VLP stabilized vaccine compositions
#437FOOD SUPPLEMENT TO PROMOTE BODY WEIGHT LOSS
#438FREEZE DRIED DRUG NANOSUSPENSIONS
#439LYOPHILIZED BENDAMUSTINE-CYCLODEXTRIN COMPOSITION
#440COMBINATION LYOPHILIZATION AND DISPENSING SYRINGE ASSEMBLY AND METHODS OF USING SAME
#441LYOPHILIZED AND STABILIZED LIVE ATTENUATED FORMULATED VACCINE AGAINST TULAREMIA
#442RNA INTERFERENCE DELIVERY FORMULATION AND METHODS FOR MALIGNANT TUMORS
#443Treatment of von Willebrand disease
#444COPPER HISTIDINATE COMPOSITIONS AND USES THEREOF
#445METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND FREEZE-DRIED FORMULATION
#446COMBINATION THERAPY WITH A VINCA ALKALOID N-OXIDE AND AN IMMUNE CHECKPOINT INHIBITOR
#447Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
#448PHARMACEUTICAL COMPOSITION CONTAINING GHRP-6
#449MICELLE RELEASING THERMOSENSITIVE HYDROGELS AS A THERAPEUTIC DELIVERY SYSTEM
#450Formulations of dengue virus vaccine compositions
#451LYOPHILIZED COMPOSITIONS COMPRISING FECAL MICROBE-BASED THERAPEUTIC AGENTS AND METHODS FOR MAKING AND USING SAME
#452Compositions and Methods for Delivering a Bacterial Metabolite to a Subject
#453Blood Plasma Product
#454Compositions, methods and uses for thermally stable multi-targeted antigens
#455COMPOSITION AND METHODS FOR STABILIZING LIQUID PROTEIN FORMULATIONS
#456Polylactic acid microsphere, polylactic-co-glycolic acid microsphere and method of preparing the same
#457LYOPHILIZED POLYMER SCAFFOLD COMPOSITIONS, PROCESSES FOR PREPARATION AND USE IN ANABOLIC WOUND REPAIR
#458USE OF CLOSTRIDIUM GHONII SPORE COMBINED WITH PEMBROLIZUMAB
#459INTRAVESICAL DELIVERY OF HYDROPHILIC THERAPEUTIC AGENTS USING LIPOSOMES
#460FORMULATIONS OF POLYALKYLENE OXIDE-ASPARAGINASE AND METHODS OF MAKING AND USING THE SAME
#461Nanoparticles Containing a Taxane and their Use
#462NALTREXONE COMPOSITIONS
#463DECOQUINATE LIPOSOME, PREPARATION METHOD THEREFOR AND USE THEREOF
#464Method for preparing active protein peptide and prepared active protein peptide and use thereof
#465FORMULATIONS OF ANTI-CD73 ANTIBODIES
#466FREEZE DRIED ANTIBODY FORMULATIONS AND METHODS THEREOF
#467ANTIBODY-DRUG CONJUGATE LYOPHILISED FORMULATION
#468BOTULINUM TOXIN FREEZE-DRIED FORMULATION DOSAGE FORM STORABLE FOR LONG TIME
#469Temperature Stable Nucleic Acid Method for Preparing Vaccines
#470PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES
#471COMPOSITIONS COMPRISING AN RNA POLYMERASE INHIBITOR AND CYCLODEXTRIN FOR TREATING VIRAL INFECTIONS
#472PHARMACEUTICAL COMPOSITION COMPRISING A DIPHENYLPYRAZINE DERIVATIVE
#473DILUTABLE FORMULATIONS OF CANNABINOIDS AND PROCESSES FOR THEIR PREPARATION
#474STABLE FORMULATION OF INTEGRIN ANTIBODY
#475IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS
#476Low Molecular Weight Silk Compositions and Stabilizing Silk Compositions
#477COMPOSITION COMPRISING LACTOBACILLUS PLANTARUM FOR PREVENTING AND/OR TREATING MENTAL ILLNESS
#478SYNTHETIC ARTIFICIAL STEM CELLS (SASC)
#479STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION
#480TREATMENT OF CANCERS AND INFECTIOUS DISEASES WITH KILLED INTACT BACTERIA
#481Daptomycin formulations
#482Lyophilized formulations of tegavivint
#483Lyophilized powder configured for reconstitution as a liquid pharmaceutical formulation with reduced viscosity and method of preparing thereof
#484MULTIVALENT NUCLEIC ACID BASED CORONAVIRUS VACCINES
#485FORMULATIONS COMPRISING RECOMBINANT ACID ALPHA-GLUCOSIDASE
#486PLATELET DERIVATIVES FOR TREATING COAGULOPATHY
#487NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT
#488CRAC CHANNEL INHIBITOR COMPOSITIONS
#489MODIFIED ANTIBODY-ALBUMIN NANOPARTICLE COMPLEXES FOR CANCER TREATMENT
#490STABLE PARENTERAL FORMULATIONS OF DULOXETINE
#491FORMULATIONS OF ANTIBODY
#492PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#493Compositions and methods for treatment
#494WATER-SOLUBLE CANNABINOID FORMULATION AND PREPARATION METHOD THEREFOR
#495PHARMACEUTICAL FORMULATIONS OF A PHENOLIC TRPV1 AGONIST PRODRUG
#496COMPLEXES COMPRISING COLLAGEN PEPTIDES AND CURCUMINOIDS AND COMPOSITIONS THEREOF
#497ANTI-GDF15 ANTIBODY AND A DOSAGE REGIMEN FOR THE TREATMENT OF CANCER
#498POLYMORPHIC FORMS OF CYCLO (-HIS-PRO) AND METHODS OF USE TO TREAT KIDNEY DISEASE
#499Preparation of preliposomal annamycin lyophilizate
#500FREEZE-DRIED ARIPIPRAZOLE FORMULATION
#501MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES
#502ORAL LIQUID SUSPENSION OF PAN-RAF KINASE INHIBITOR
#503PHARMACEUTICAL COMPOSITIONS COMPRISING PARTICLES AND MRNA AND METHODS FOR PREPARING AND STORING THE SAME
#504THERAPEUTIC AGENT FOR NERVE DISORDERS
#505Fecal microbiota transplant compositions and methods of manufacture
#506FOSPHENYTOIN SODIUM SOLID COMPOSITION, LYOPHILIZATION METHOD, AND USE OF FOSPHENYTOIN SODIUM SOLID COMPOSITION
#507METHOD OF ORALLY ADMINISTERING A FECAL MICROBIOTA TRANSPLANT COMPOSITION
#508PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY-DRUG CONJUGATE, AND USE OF PHARMACEUTICAL COMPOSITION
#509ALLERGEN PREPARATION
#510Synthetic platelets
#511INHALATION FORMULATIONS OF 1`-CYANO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS
#512MEDICINE PRODUCTION METHOD INCLUDING STEP OF FREEZE-DRYING WITH MIXED SOLVENT
#513CYCLOSPORINE FORMULATIONS FOR USE IN THE PREVENTION OR TREATMENT OF PULMONARY CHRONIC GRAFT REJECTION
#514Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders
#515DUAL ANALGESIC/ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CB2 RECEPTOR AGONISTS, COMBINATIONS, AND METHODS OF USE THEREOF
#516PREPARATION OF HIGHLY CONCENTRATED ALLERGENIC INTERMEDIATE
#517FREEZE-DRIED MICROBUBBLES, THEIR USE, AND METHOD FOR PRODUCING THE SAME
#518PEGYLATED RAPAMYCIN COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#519COMPOUNDS AND COMPOSITIONS FOR TREATING SOLID TUMORS BY INTRATUMORAL ADMINISTRATION
#520TETRAZOLE DERIVATIVES
#521METHODS OF TREATING AUTOIMMUNE OR INFLAMMATORY CONDITIONS WITH CANNABIDIOL OR ITS DERIVATIVES/ANALOGS
#522CANNABINOIDS IN THE TREATMENT OF AUTISM SPECTRUM DISORDER
#523METHODS OF MAKING LIPID NANOPARTICLES
#524RAPIDLY INFUSING COMPOSITIONS FOR ORAL MUCOSAL DELIVERY AND METHODS
#525PACKAGING FOR RAPIDLY INFUSING COMPOSITION
#526MULTI-SUPPLEMENT DELIVERY SYSTEM
#527RAPIDLY INFUSING COMPOSITIONS WITH SUPPLEMENTS AND TREATMENT METHODS
#528FORMULATIONS
#529Lyophilization syringe
#530Compositions and methods for nanoparticle lyophile forms
#531USE OF SURFACTANT WITH HIGH MOLECULAR WEIGHT FISH GELATIN BASED DOSAGE FORMULATIONS TO IMPROVE FLOW CHARACTERISTICS
#532ANTI-CD38 ANTIBODIES AND FORMULATIONS
#533LYOPHILIZED PHARMACEUTICAL COMPOSITION AND USES OF A CRYSTALLIZED FORM OF LURBINECTEDIN
#534RAPIDLY INFUSING COMPOSITIONS WITH METHOTREXATE AND TREATMENT METHODS
#535RAPIDLY INFUSING CANNABINOID COMPOSITIONS, PROCESSES OF MANUFACTURE, AND METHODS OF USE
#536FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION
#537ENHANCED FORMULATION STABILIZATION AND IMPROVED LYOPHILIZATION PROCESSES
#538PUNCTAL PLUGS CONTAINING MICELLE-ENCAPSULATED OPHTHALMIC PHARMACEUTICALS AND METHODS FOR MAKING THEREOF
#539SYSTEM AND METHOD FOR MEASURING RAPID DECOMPRESSION ICE NUCLEATION IN LYOPHILIZATION
#540COMBINATION PRODUCT FOR PROPHYLAXIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME
#541USE OF A GROWTH FACTORS-ENRICHED DRY POWDER FOR RELIEVING INFLAMMATION OR INJURY
#542Polyomavirus neutralizing antibodies
#543CRYSTALLIZED FORM OF LURBINECTEDIN AND METHOD OF MAKING THE SAME
#544A LYOPHILIZED PHARMACEUTICAL COMPOSITION
#545PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HUMAN TSLP RECEPTOR ANTIBODY
#546COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#547TREATMENT OF RADICULAR PAIN WITH CELL-FREE AMNIOTIC FLUID
#548Remote loading of sparingly water-soluble drugs into lipid vesicles
#549COMPOSITION INHIBITING MUSCLE LOSS OR PROMOTING MUSCLE FORMATION THROUGH SKIN-DERIVED EXOSOMES
#550System and method directed to an eyeglasses-type wearable device
#551MEDICAL DEVICE CONTAINING A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT, AND A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT.
#552OPTIMIZED RATIOS OF AMINO ACIDS AND SUGARS AS AMORPHOUS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS
#553LYOPHILIZED PHARMACEUTICAL COMPOSITIONS OF COPPER HISTIDINATE
#554Compounds and methods for treating or preventing anterior segment ocular disorders and/or retinal degenerations
#555VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
#556ANTI-IL-36R ANTIBODY FORMULATIONS
#557IMPROVED PROCESS AND FORMULATION OF LIPID NANOPARTICLES
#558LYOPHILIZED COMPOSITION COMPRISING (S)-ISOPROPYL 2-((S)-2-ACETAMIDO-3-(1H-INDOL-3-YL)PROPANAMIDO)-6-DIAZO-5-OXOHEXANOATE FOR SUBCUTANEOUS ADMINISTRATION AND THE USE THEREOF
#559STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND HYALURONIDASE VARIANTS AND FRAGMENTS THEREOF AND METHODS OF USE THEREOF
#560USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
#561METHOD FOR LYOPHILIZING LIVE VACCINE STRAINS OF FRANCISELLA TULARENSIS
#562MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE
#563Methods and articles of manufacture for animal therapeutics
#564Stabilized formulations of lipid nanoparticles
#565BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION
#566LYOPHILIZATION PROCESS AND A TEVERELIX-TFA LYOPHILIZATE OBTAINED THEREBY
#567Target residual moisture content for lyophilized drug product
#568MANUFACTURE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE (III)] AND COMPOSITIONS THEREOF
#569TRISULFIDE COMPOUND
#570Marine polysaccharide vector-based anthocyanin nanoparticles, and preparation method therefor and application thereof in targeted delivery
#571Non-protein Clostridial toxin compositions
#572Non-protein clostridial toxin compositions
#573Lyophilized formulation
#574SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS
#575Pharmaceutical Composition Containing Elemene, Preparation Method Therefor, And Use Thereof
#576VACCINE COMPOSITIONS FOR MUCOSAL IMMUNE RESPONSE
#577PHARMACEUTICAL COMPOSITIONS OF CHEMOTHERAPEUTIC AGENTS BASED ON BETA-SUBSTITUTED BETA-AMINO ACID DERIVATIVES
#578PHARMACEUTICAL FORMULATION
#579Probiotic Lyophilizate Reactivation Composition for Improving Intestinal Survivability and Adhesion of Probiotics
#580BLOOD PLASMA-CONTAINING COMPOSITIONS
#581STABLE FORMULATIONS OF ANTI-CANCER PEPTIDES
#582Pharmaceutical formulations
#583LYOPHILISATE RETAINER, METHOD OF MANUFACTURING THEREOF AND PROCEDURE OF DRYING A SUBSTRATE
#584ANTIBODY-NANOPARTICLE COMPLEXES AND METHODS FOR MAKING AND USING THE SAME
#585Metal aluminum nano-adjuvant, vaccine composition and preparation method therefor and use thereof
#586METHOD FOR PREPARING A VACCINE COMPOSITION FROM LYOPHILIZED ANTIGENS
#587METHOD FOR SCREENING INDIVIDUAL TUMOR NEOANTIGEN PEPTIDE, AND VACCINE FORMULATION THEREOF
#588Biodegradable polymer microsphere compositions for parenteral administration
#589METHODS FOR THE TREATMENT OF LUNG TUMORS
#590Amphiregulin gene-specific double-stranded oligonucleotide and composition for preventing and treating fibrosis-related diseases and respiratory diseases, comprising same
#591IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS
#592HYPERBRANCHED POLYESTER POLYOL DERIVATIVE AS DRUG SOLUBILIZER
#593NOROVIRUS VACCINE
#594MICROORGANISM STRAIN PEDIOCOCCUS ACIDILACTICI TAK 589 COCCOBEST AS AN ANTIMICROBIAL AND ANTIOXIDANT PROBIOTIC
#595Pairing probiotics and prebiotics, methods for growth and use, separately and in combination
#596INTESTINAL MICROBIOTA BACTERIA AND COMPOSITION CONTAINING SAME FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES CHARACTERISED BY EXCESS 2-HYDROXYGLUTARATE
#597Large Fast Dispersing Tablet Prepared By Lyophilization
#598Continuous throughput lyophilizer-powder filler within a sterile boundary
#599Anti-BTN3A antibodies and their use in treating cancer or infectious disorders
#600Near infrared fluorescent dyes, formulations and related methods